Renal artery stenting using gadodiamide arteriography in patients with baseline renal insufficiency

Tareq S. Harb, John R. Laird, Robert S. Dieter, Bhagat K. Reddy, Donna Whitman, Joseph C. Babrowicz, Lowell F. Satler

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Purpose: To investigate whether a contrast agent containing gadodiamide can reduce the incidence of contrast-induced nephropathy associated with renal artery stenting in patients with preexisting renal insufficiency. Methods: Between 1999 and 2002, gadodiamide-based arteriography was used in 20 patients (12 men; mean age 69 years) with significant baseline renal insufficiency (creatinine ≥1.7 mg/dL) undergoing renal artery stenting for ≥70% stenoses in 25 renal arteries. Baseline creatinine levels were compared to postprocedure and midterm follow-up levels. Results: Procedural success was 100%. An average of 74 mL of gadodiamide contrast was used per case. Four patients received an additional 30 mL (mean) of iodinated contrast due to poor image quality with gadodiamide alone. There was no significant change in mean creatinine levels at discharge (2.9 mg/dL) compared to baseline (3.0 mg/dL, p=0.72). At midterm follow-up, mean creatinine levels (2.4 mg/dL) were significantly lower compared to baseline; (p=0.004). Conclusions: Gadodiamide-based arteriography can be effectively used during RAS in patients with baseline renal insufficiency. This technique may enhance the renal-protective effect of renal artery stenting in this high-risk population with renal artery stenosis.

Original languageEnglish (US)
Pages (from-to)553-559
Number of pages7
JournalJournal of Endovascular Therapy
Volume11
Issue number5
DOIs
StatePublished - Oct 2004
Externally publishedYes

Fingerprint

gadodiamide
Renal Artery
Renal Insufficiency
Angiography
Creatinine
Renal Artery Obstruction
Contrast Media
Pathologic Constriction
Kidney

Keywords

  • Complication
  • Digital subtraction angiography
  • Gadodiamide
  • Gadolinium
  • Renal artery stenting
  • Renal insufficiency
  • Serum creatinine

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Harb, T. S., Laird, J. R., Dieter, R. S., Reddy, B. K., Whitman, D., Babrowicz, J. C., & Satler, L. F. (2004). Renal artery stenting using gadodiamide arteriography in patients with baseline renal insufficiency. Journal of Endovascular Therapy, 11(5), 553-559. https://doi.org/10.1583/04-1234.1

Renal artery stenting using gadodiamide arteriography in patients with baseline renal insufficiency. / Harb, Tareq S.; Laird, John R.; Dieter, Robert S.; Reddy, Bhagat K.; Whitman, Donna; Babrowicz, Joseph C.; Satler, Lowell F.

In: Journal of Endovascular Therapy, Vol. 11, No. 5, 10.2004, p. 553-559.

Research output: Contribution to journalArticle

Harb, TS, Laird, JR, Dieter, RS, Reddy, BK, Whitman, D, Babrowicz, JC & Satler, LF 2004, 'Renal artery stenting using gadodiamide arteriography in patients with baseline renal insufficiency', Journal of Endovascular Therapy, vol. 11, no. 5, pp. 553-559. https://doi.org/10.1583/04-1234.1
Harb, Tareq S. ; Laird, John R. ; Dieter, Robert S. ; Reddy, Bhagat K. ; Whitman, Donna ; Babrowicz, Joseph C. ; Satler, Lowell F. / Renal artery stenting using gadodiamide arteriography in patients with baseline renal insufficiency. In: Journal of Endovascular Therapy. 2004 ; Vol. 11, No. 5. pp. 553-559.
@article{8373f7243ac4416d88fdb190854e8ec0,
title = "Renal artery stenting using gadodiamide arteriography in patients with baseline renal insufficiency",
abstract = "Purpose: To investigate whether a contrast agent containing gadodiamide can reduce the incidence of contrast-induced nephropathy associated with renal artery stenting in patients with preexisting renal insufficiency. Methods: Between 1999 and 2002, gadodiamide-based arteriography was used in 20 patients (12 men; mean age 69 years) with significant baseline renal insufficiency (creatinine ≥1.7 mg/dL) undergoing renal artery stenting for ≥70{\%} stenoses in 25 renal arteries. Baseline creatinine levels were compared to postprocedure and midterm follow-up levels. Results: Procedural success was 100{\%}. An average of 74 mL of gadodiamide contrast was used per case. Four patients received an additional 30 mL (mean) of iodinated contrast due to poor image quality with gadodiamide alone. There was no significant change in mean creatinine levels at discharge (2.9 mg/dL) compared to baseline (3.0 mg/dL, p=0.72). At midterm follow-up, mean creatinine levels (2.4 mg/dL) were significantly lower compared to baseline; (p=0.004). Conclusions: Gadodiamide-based arteriography can be effectively used during RAS in patients with baseline renal insufficiency. This technique may enhance the renal-protective effect of renal artery stenting in this high-risk population with renal artery stenosis.",
keywords = "Complication, Digital subtraction angiography, Gadodiamide, Gadolinium, Renal artery stenting, Renal insufficiency, Serum creatinine",
author = "Harb, {Tareq S.} and Laird, {John R.} and Dieter, {Robert S.} and Reddy, {Bhagat K.} and Donna Whitman and Babrowicz, {Joseph C.} and Satler, {Lowell F.}",
year = "2004",
month = "10",
doi = "10.1583/04-1234.1",
language = "English (US)",
volume = "11",
pages = "553--559",
journal = "Journal of Endovascular Therapy",
issn = "1526-6028",
publisher = "International Society of Endovascular Specialists",
number = "5",

}

TY - JOUR

T1 - Renal artery stenting using gadodiamide arteriography in patients with baseline renal insufficiency

AU - Harb, Tareq S.

AU - Laird, John R.

AU - Dieter, Robert S.

AU - Reddy, Bhagat K.

AU - Whitman, Donna

AU - Babrowicz, Joseph C.

AU - Satler, Lowell F.

PY - 2004/10

Y1 - 2004/10

N2 - Purpose: To investigate whether a contrast agent containing gadodiamide can reduce the incidence of contrast-induced nephropathy associated with renal artery stenting in patients with preexisting renal insufficiency. Methods: Between 1999 and 2002, gadodiamide-based arteriography was used in 20 patients (12 men; mean age 69 years) with significant baseline renal insufficiency (creatinine ≥1.7 mg/dL) undergoing renal artery stenting for ≥70% stenoses in 25 renal arteries. Baseline creatinine levels were compared to postprocedure and midterm follow-up levels. Results: Procedural success was 100%. An average of 74 mL of gadodiamide contrast was used per case. Four patients received an additional 30 mL (mean) of iodinated contrast due to poor image quality with gadodiamide alone. There was no significant change in mean creatinine levels at discharge (2.9 mg/dL) compared to baseline (3.0 mg/dL, p=0.72). At midterm follow-up, mean creatinine levels (2.4 mg/dL) were significantly lower compared to baseline; (p=0.004). Conclusions: Gadodiamide-based arteriography can be effectively used during RAS in patients with baseline renal insufficiency. This technique may enhance the renal-protective effect of renal artery stenting in this high-risk population with renal artery stenosis.

AB - Purpose: To investigate whether a contrast agent containing gadodiamide can reduce the incidence of contrast-induced nephropathy associated with renal artery stenting in patients with preexisting renal insufficiency. Methods: Between 1999 and 2002, gadodiamide-based arteriography was used in 20 patients (12 men; mean age 69 years) with significant baseline renal insufficiency (creatinine ≥1.7 mg/dL) undergoing renal artery stenting for ≥70% stenoses in 25 renal arteries. Baseline creatinine levels were compared to postprocedure and midterm follow-up levels. Results: Procedural success was 100%. An average of 74 mL of gadodiamide contrast was used per case. Four patients received an additional 30 mL (mean) of iodinated contrast due to poor image quality with gadodiamide alone. There was no significant change in mean creatinine levels at discharge (2.9 mg/dL) compared to baseline (3.0 mg/dL, p=0.72). At midterm follow-up, mean creatinine levels (2.4 mg/dL) were significantly lower compared to baseline; (p=0.004). Conclusions: Gadodiamide-based arteriography can be effectively used during RAS in patients with baseline renal insufficiency. This technique may enhance the renal-protective effect of renal artery stenting in this high-risk population with renal artery stenosis.

KW - Complication

KW - Digital subtraction angiography

KW - Gadodiamide

KW - Gadolinium

KW - Renal artery stenting

KW - Renal insufficiency

KW - Serum creatinine

UR - http://www.scopus.com/inward/record.url?scp=7244242276&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7244242276&partnerID=8YFLogxK

U2 - 10.1583/04-1234.1

DO - 10.1583/04-1234.1

M3 - Article

VL - 11

SP - 553

EP - 559

JO - Journal of Endovascular Therapy

JF - Journal of Endovascular Therapy

SN - 1526-6028

IS - 5

ER -